These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 25049084)
1. Drug eluting devices for critically ill patients: can we apply lessons learned from the treatment of peripheral artery disease? Werner M; Scheinert D Adv Drug Deliv Rev; 2014 Nov; 77():32-9. PubMed ID: 25049084 [TBL] [Abstract][Full Text] [Related]
2. Does endovascular treatment of infra-inguinal arterial disease with drug-eluting stents offer better results than angioplasty with or without bare metal stents? Antoniou GA; Georgakarakos EI; Antoniou SA; Georgiadis GS Interact Cardiovasc Thorac Surg; 2014 Aug; 19(2):282-5. PubMed ID: 24729201 [TBL] [Abstract][Full Text] [Related]
3. 12-month primary patency rates of contemporary endovascular device therapy for femoro-popliteal occlusive disease in 6,024 patients: beyond balloon angioplasty. Marmagkiolis K; Hakeem A; Choksi N; Al-Hawwas M; Edupuganti MM; Leesar MA; Cilingiroglu M Catheter Cardiovasc Interv; 2014 Oct; 84(4):555-64. PubMed ID: 24740749 [TBL] [Abstract][Full Text] [Related]
4. Drug delivering technology for endovascular management of infrainguinal peripheral artery disease. Sarode K; Spelber DA; Bhatt DL; Mohammad A; Prasad A; Brilakis ES; Banerjee S JACC Cardiovasc Interv; 2014 Aug; 7(8):827-39. PubMed ID: 25147028 [TBL] [Abstract][Full Text] [Related]
5. Drug-coated balloons to improve femoropopliteal artery patency: Rationale and design of the LEVANT 2 trial. Jaff MR; Rosenfield K; Scheinert D; Rocha-Singh K; Benenati J; Nehler M; White CJ Am Heart J; 2015 Apr; 169(4):479-85. PubMed ID: 25819854 [TBL] [Abstract][Full Text] [Related]
6. Drug-coated balloons vs. drug-eluting stents for treatment of long femoropopliteal lesions. Zeller T; Rastan A; Macharzina R; Tepe G; Kaspar M; Chavarria J; Beschorner U; Schwarzwälder U; Schwarz T; Noory E J Endovasc Ther; 2014 Jun; 21(3):359-68. PubMed ID: 24915582 [TBL] [Abstract][Full Text] [Related]
7. Local delivery of paclitaxel in the treatment of peripheral arterial disease. Ng VG; Mena C; Pietras C; Lansky AJ Eur J Clin Invest; 2015 Mar; 45(3):333-45. PubMed ID: 25615282 [TBL] [Abstract][Full Text] [Related]
8. Drug-eluting stents and balloons in peripheral arterial disease: evidence so far. Chan YC; Cheng SW Int J Clin Pract; 2011 Jun; 65(6):664-8. PubMed ID: 21564438 [TBL] [Abstract][Full Text] [Related]
11. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Liistro F; Porto I; Angioli P; Grotti S; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L Circulation; 2013 Aug; 128(6):615-21. PubMed ID: 23797811 [TBL] [Abstract][Full Text] [Related]
12. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis. Herten M; Torsello GB; Schönefeld E; Imm B; Osada N; Stahlhoff S J Vasc Surg; 2015 Feb; 61(2):394-9. PubMed ID: 25307133 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ; J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459 [TBL] [Abstract][Full Text] [Related]
14. Drug-eluting stents for treatment of focal infrapopliteal lesions. Rastan A; Noory E; Zeller T Vasa; 2012 Mar; 41(2):90-5. PubMed ID: 22403126 [TBL] [Abstract][Full Text] [Related]
15. Drug coated balloon angioplasty in the treatment of peripheral artery disease. Colleran R; Harada Y; Cassese S; Byrne RA Expert Rev Med Devices; 2016 Jun; 13(6):569-82. PubMed ID: 27152654 [TBL] [Abstract][Full Text] [Related]